Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Diabetic Nephropathy

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Chronological Changes in Causes of Death in Brain Death Donors: A 7-Year Analysis in the Tuscany Region.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026

Same author

Infectious Risk Donor Status in Uncontrolled Donation After Circulatory Death and Liver Transplantation.

Transplant infectious disease : an official journal of the Transplantation Society·2026

Same author

Success is not final, failure is not fatal; it is the courage to continue (improving) that counts.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026

Same author

A Decline in Donors After Brain Death: A Transient Phenomenon?

Transplantation·2026

Same author

Out of hospital cardiac arrest, uncontrolled donation after circulatory death only lung and lung transplants.

Resuscitation·2026

Same author

Cytokines Adsorption During Ex Situ Machine Perfusion of Liver Grafts from Elderly Donors: A Pilot, Prospective, Randomized Study.

Life (Basel, Switzerland)·2026

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

The diabetic cardiomyopathy.

Roberto Tarquini¹, Chiara Lazzeri, Laura Pala

¹Department of Internal Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy. rtarquini@unifi.it

Acta Diabetologica

|March 4, 2010

Summary

This summary is machine-generated.

Diabetic cardiomyopathy, characterized by heart dysfunction in diabetics, is common even in asymptomatic patients. Early screening via microalbuminuria or echocardiogram can prevent heart failure progression.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Experiment Videos

Last Updated: Jun 15, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Area of Science:

Cardiology
Endocrinology
Metabolic Diseases

Background:

Diabetic cardiomyopathy is defined by myocardial abnormalities in diabetic patients without other causes.
Diabetes significantly increases heart failure risk; 75% of idiopathic dilated cardiomyopathy cases are linked to diabetes.
Microvascular complications in diabetics show a strong association with cardiomyopathy, correlating with hyperglycemia severity and duration.

Purpose of the Study:

To define diabetic cardiomyopathy and its diagnostic criteria.
To explore the link between diabetes, metabolic abnormalities, and cardiac dysfunction.
To highlight the importance of early screening for diabetic cardiomyopathy to prevent heart failure.

Main Methods:

Diagnosis relies on identifying myocardial abnormalities and excluding other causes.
Non-invasive imaging techniques are used to detect myocardial dysfunction.
Microalbuminuria and standard echocardiography are key diagnostic and screening tools.

Main Results:

Metabolic abnormalities (hyperglycemia, hyperinsulinemia, hyperlipemia) cause cellular changes like fibrosis and hypertrophy.
These changes can occur directly or indirectly via mechanisms like renin-angiotensin system activation.
Diabetic cardiomyopathy is prevalent in asymptomatic type 2 diabetics.

Conclusions:

Early detection of diabetic cardiomyopathy is crucial for preventing heart failure progression.
Screening asymptomatic type 2 diabetics is recommended.
Microalbuminuria offers a cost-effective pre-screening method, while echocardiography is the most sensitive test.